Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry.
about
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.Modern LC in therapeutic drug monitoring and diagnosis of pediatric leukemia.Antineoplastic drugs and their analysis: a state of the art review.Quantitative determination of imatinib stability under various stress conditionsComment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance.Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance.Therapeutic drug monitoring and tyrosine kinase inhibitors.Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.Biliary excretion of imatinib mesylate and its metabolite CGP 74588 in humans.The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate.Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients.
P2860
Q37085189-F05DE43E-E726-4D1C-A800-8126D3B73C30Q38285133-686B621D-4072-4064-A540-B04E134267C1Q39339684-D8FD40E7-5CBC-4D00-86C0-CF6E9F519D8AQ39443604-D28CFEE4-1489-4588-B9D6-345FA6A25FEBQ41501511-4D6C93EF-16E9-484B-9A85-9E6EC94EDB01Q41501849-DCAE2EA4-EC7F-492A-A346-A88462FD3C5BQ41846251-7246F53A-B208-4F99-86B7-E67C8F45578DQ44745256-51CE59D1-3C6F-4949-81BA-9799B94BA75DQ45087236-9A8B92A5-D49B-44AB-A862-42BE628D6012Q45146720-CD154E7B-F218-4E35-96FF-E0780ECD363EQ54578490-9F33859F-953D-4DCE-87D0-F42C8D1FEF29
P2860
Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@ast
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@en
type
label
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@ast
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@en
prefLabel
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@ast
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@en
P2093
P1476
Quantification of the anti-leu ...... aphy-tandem mass spectrometry.
@en
P2093
P304
P356
10.1016/S0731-7085(02)00080-8
P577
2002-06-01T00:00:00Z